SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001654954-19-001595
Filing Date
2019-02-14
Accepted
2019-02-14 21:50:57
Documents
1
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT section16.html 5  
1 PRIMARY DOCUMENT section16.xml 5 8244
  Complete submission text file 0001654954-19-001595.txt   9752
Mailing Address 1345 AVENUE OF THE AMERICAS 11TH FLOOR NEW YORK NY 10105
Business Address 1345 AVENUE OF THE AMERICAS 11TH FLOOR NEW YORK NY 10105 (347) 905 5663
Cellular Biomedicine Group, Inc. (Issuer) CIK: 0001378624 (see all company filings)

IRS No.: 861032927 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address 530 UNIVERSITY AVENUE, #17 PALO ALTO CA 94301
Business Address
Liu Tony (Reporting) CIK: 0001569983 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-36498 | Film No.: 19609670